LSDIF (Lucy Scientific Discovery) Net Change in Cash: $0.19 Mil (TTM As of Dec. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Lucy Scientific Discovery Net Change in Cash?

Lucy Scientific Discovery LSDIF Net Change in Cash is $0.19 Mil as of Dec. 2023.

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Lucy Scientific Discovery's Net Change in Cash for the three months ended in Dec. 2023 was $-0.01 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2023 was $0.19 Mil.

Lucy Scientific Discovery Net Change in Cash Historical Data

* Premium members only.

The historical data trend for Lucy Scientific Discovery's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lucy Scientific Discovery Net Change in Cash Chart

Lucy Scientific Discovery Annual Data
Trend Jun20 Jun21 Jun22 Jun23
Net Change in Cash
0.04 0.20 -0.19 1.62

Lucy Scientific Discovery Quarterly Data
Sep20 Dec20 Sep21 Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Net Change in Cash Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 3.36 -1.72 -1.44 -0.01

Lucy Scientific Discovery Net Change in Cash Calculation

Lucy Scientific Discovery's Net Change in Cash for the fiscal year that ended in Jun. 2023 is calculated as

Net Change in Cash= Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=-4.2663530000231+-0.26589400000144+6.1922880000336+-0.039546000000214
=1.62

Lucy Scientific Discovery's Net Change in Cash for the quarter that ended in Dec. 2023

Net Change in Cash=Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=-0.31801898956017+0.000968370749298+0.75104316616347+-0.043444397326131
=0.39

Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.19 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Change in Cash →
What does a Net Change in Cash of $0.19 Mil mean?
Lucy Scientific Discovery (LSDIF) has a Net Change in Cash of $0.19 Mil as of Dec. 2023. The net change in cash is the total change in cash and equivalents between the current period and the past period. View historical data for Lucy Scientific Discovery and its competitors.
Is Lucy Scientific Discovery's Net Change in Cash too high?
Lucy Scientific Discovery's current Net Change in Cash is $0.19 Mil.
How does Lucy Scientific Discovery's Net Change in Cash compare to INQD and ZTS?
Lucy Scientific Discovery's Net Change in Cash of $0.19 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Change in Cash for a Drug Manufacturers company?
A good Net Change in Cash depends on the Drug Manufacturers industry context. However, Net Change in Cash should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Change in Cash mean?
A high Net Change in Cash can signal that a stock is expensive relative to its fundamentals. The net change in cash is the total change in cash and equivalents between the current period and the past period. View historical data for Lucy Scientific Discovery and its competitors. Lucy Scientific Discovery's current Net Change in Cash is $0.19 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lucy Scientific Discovery stock overvalued right now?
Lucy Scientific Discovery (LSDIF) has a current Net Change in Cash of $0.19 Mil. The current Net Change in Cash is $0.19 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Change in Cash calculated?
Net Change in Cash is calculated from a company's financial statements. For Lucy Scientific Discovery (LSDIF), the current Net Change in Cash is $0.19 Mil as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lucy Scientific Discovery Business Description

Address 301-1321 Blanshard Street, Victoria, BC, CAN, V8W 0B6
Lucy Scientific Discovery Inc is an early-stage psychotropics contract manufacturing company focused on becoming the contract research, development, and manufacturing organization for the emerging psychotropics-based medicines industry. Its drug products are designed to treat a range of mental health and cognitive conditions.